Explore Research Materials The peptide industry was shaken recently when Eli Lilly filed lawsuits against several companies accused of selling products purported to contain Retatrutide, the company's highly anticipated investigational obesity and diabetes drug. Retatrutide has generated significant attention because of promising clinical trial results, but it has not yet received FDA approval for human use. According to Lilly, the lawsuits target companies that are allegedly

Explore Research Materials Peptide research has become one of the most exciting areas in modern biomedical science. Over the last decade, researchers have expanded our understanding of how small chains of amino acids can influence healing, metabolism, cellular communication, and disease treatment. While many studies are still ongoing, several areas of peptide research have had a significant impact on the scientific community and continue to shape future investigations. One of

Yesterday, an FDA advisory panel voted to recommend easing restrictions on BPC-157, a peptide that has gained significant attention among athletes, wellness enthusiasts, and practitioners of regenerative medicine. The recommendation could potentially expand future access to BPC-157 through compounding pharmacies, though the FDA has not yet made a final decision. BPC-157 has developed a devoted following because of claims that it may support tissue repair, recovery, gut health